The FDA had requested the stay while it continues a safety review of the abortion drug.

A federal judge in Texas on Aug. 30 paused a lawsuit seeking to revoke nationwide approval of the abortion drug mifepristone, saying the case won’t be heard until at least Dec. 1 and granting the U.S. Food and Drug Administration’s request for a stay to continue its safety review of the drug.

The Republican attorneys general of Florida and Texas filed a lawsuit against the FDA last December seeking to permanently revoke the agency’s initial approval of mifepristone from 2000, along with subsequent decisions over the years that eased access for patients. Florida and Texas had agreed to the FDA’s request for a stay. 

If a judge were to rule in favor of Florida and Texas, the medication would become........

© Rewire.News